• Return to Headlines

Shares of LGND Down 21.2% Since Downtrend Call on Shares

By Nick Russo

SmarTrend identified a Downtrend for Ligand Pharm (NASDAQ:LGND) on May 10th, 2019 at $116.57. In approximately 4 months, Ligand Pharm has returned 21.25% as of today's recent price of $91.80.

Over the past year, Ligand Pharm has traded in a range of $84.74 to $278.62 and is now at $91.56, 8% above that low. Over the past week, the 200-day moving average (MA) has gone down 1% while the 50-day MA has declined 1.7%.

Ligand Pharmaceuticals Incorporated develops drugs which regulate hormone activated intracellular receptors. These receptors play a role in regulating the genetic processes affecting diseases such as gynecological disorders and certain cancers, as well as cardiovascular, inflammatory, and skin diseases.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Ligand Pharm.

Log in and add Ligand Pharm (LGND) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights ligand pharm

Ticker(s): LGND